The application of recently developed research techniques to the study of tumour invasion and metastasis has uncovered new and surprising information which has focused increasing clinical and scientific interest on this aspect of neoplasia. The magnitude of the effect of this problem on health is revealed by reference to the annual mortality statistics published by the Registrar General of England and Wales. These show that about one in three of the population die of the consequences of metastatic cancer, or are found to harbour asymptomatic metastatic tumour deposits at necropsy. Research on this subject is therefore directed at controlling a major, clinically important phenomenon. A selection of recent advances which offer new opportunities for early diagnosis or treatment of this aspect of malignant disease are surveyed in this brief overview.
Introduction
The application of recently developed research techniques to the study of tumour invasion and metastasis has uncovered new and surprising information which has focused increasing clinical and scientific interest on this aspect of neoplasia. The magnitude of the effect of this problem on health is revealed by reference to the annual mortality statistics published by the Registrar General of England and Wales. These show that about one in three of the population die of the consequences of metastatic cancer, or are found to harbour asymptomatic metastatic tumour deposits at necropsy. Research on this subject is therefore directed at controlling a major, clinically important phenomenon. A selection of recent advances which offer new opportunities for early diagnosis or treatment of this aspect of malignant disease are surveyed in this brief overview.
Clinical and experimental background The invasive and metastatic activity of malignant tumours has, until now, seemed to be an almost insuperable problem, best illustrated by a clinical example. The patient whose leg is shown in fig 1A had initially presented two years earlier with a small melanoma. This was treated by wide local excision and grafting of skin from the back of her torso. Subsequently an advancing wave of dermal metastases ( fig  1B) gradually ascended her leg. Metastatic tumour then colonised and replaced her inguinal lymph nodes and went on progressively to take over the para-aortic group. Finally, haematogenous metastasis began, evidenced by the presence of pigmented tumour deposits in the brain at necropsy ( fig 1C) . Death, in this case, was due to an unrelated condition, but is more often due in disseminated malignancy, to organ failure following replacement by tumour ( fig ID) . As the metastases in this patient only appeared after excision of the small primary tumour, they must have already been disseminated. Equally, the eventual appearance of metastatic deposits in the grafted skin ( fig 1A) , donated from a remote site which never developed dermal secondaries, illustrates that metastases themselves act as new foci for further dissemination, resulting in a geometric increase in the impact ofthe tumour on the host.
Clinical experience, therefore, teaches that malignancy is often already systemic from very early in the life history of a neoplasm and that patients may harbour many covert seedling tumours at the time of first presentation with symptomatic lumps. Diagnostic and therapeutic policy need to be predicated on this understanding. As Early tumour diagnosis as a practical means of controlling metastatic sequelae Recent studies have provided evidence that the activity of the CD44 gene is severely deranged in many types of tumours.'3-16 This gene normally codes for a family of heavily glycosylated cell surface proteins, the multiple isoforms of which exercise many important cellular functions.'8 In cancer there is chaotic overproduction of many unusual mRNA transcripts, relative to the picture seen in corresponding normal or non-neoplastic tissues. As the disorder is present in early tumours (Matsumura et al, unpublished observations) and can be identified in very small samples using amplification techniques, it seems a promising candidate to study as a possible marker for early diagnosis and for monitoring patients for local and distant recurrent disease. '3 The first observation that there is gross overexpression of numerous splice variants from this gene in human tumour tissue was serendipitously made in the course of studying metastatic cells to test the hypothesis'9 that such cells are inappropriately activating genetic programmes for white cell (especially lymphocyte) recirculatory traffic. An earlier study in Very recently results from three laboratories3032 have indicated that counting the number of capillaries in the most vascularised area of a tumour might give a useful pragmatic indication of patient survival or of tumour recurrence in breast cancer and non-small cell lung cancer. The underlying basis for this clinical evaluation is the well established knowledge that vascularisation is essential for tumours to grow beyond a few millimetres in size, and for dissemination of tumours by blood and lymphatic routes. Although there is very good statistical correlation between vessel density in histological sections and prognosis, it remains to be seen in further studies whether it is a useful index for the evaluation of individual patients. specific factors may influence metastatic colonisation9-11 and raised the idea that purification and identication of the natural agents which can inhibit formation of metastasis could provide a novel, natural, and possibly non-toxic, form of treatment for established metastatic disease.
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The above brief summary indicates that research on tumour invasion and metastasis is becoming very active and is yielding information that is both of potential clinical value and of help for unravelling the mechanisms involved. The pace is accelerating and it would not be unreasonable to expect major advances towards control of this phenomenon in the next few years.
